HPV Testing And Pap Test Market Progressing At USD 5.6 Billion By 2024 : Grand View Research Inc.
San Francisco, 19 September 2019: The Report HPV Testing And Pap Test Market Analysis by Test Type (HPV Test, Pap Test), By Application (Cervical Cancer Screening, Vaginal Cancer Screening), By End-user (Point-of-care, Central laboratories) And Segment Forecasts To 2024 The global human papillomavirus (HPV) testing and pap test market are expected to reach USD 5.6 billion by 2024, according to a new report by Grand View Research Inc.The market is majorly driven by the increasing number of cervical cancer cases, government initiatives, and the heightened awareness amongst women about cervical cancer. For instance, the CDC advocates cervical cancer screening tests for women above the age of 30 as it was found that the cervical cancers are rare in the age group, 20-30 years (2 in 100,000) as compared to the older age groups (16 in 100,000). In addition to carrying out awareness campaigns, the government and key industrial players are providing funding to universities for the de